Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Grabowski

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Health Physics|August 1, 1972
Long-term study of the urinary Strontium-90 and calcium in childrenW Czosnowska, Z Pietrzak-Flis, D Grabowski
Diabetic Medicine : a Journal of the British Diabetic Association|July 4, 2020
The psychosocial experience and needs of children newly diagnosed with type 1 diabetes from their own perspective: a systematic and narrative reviewP DeCosta, D Grabowski, T C Skinner
European Journal of Cancer & Clinical Oncology|June 1, 1984
Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cellsR Ganapathi, D Grabowski, R Turinic, et al.
Biochemical Pharmacology|October 1, 1990
Modulation of doxorubicin-induced chromosomal damage by calmodulin inhibitors and its relationship to cytotoxicity in progressively doxorubicin-resistant tumor cellsR Ganapathi, D Grabowski, G Hoeltge, et al.
Cancer Research|July 15, 1993
Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin)R Ganapathi, A Hercbergs, D Grabowski, et al.
British Journal of Cancer|June 1, 1993
Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotypeN Kamath, D Grabowski, J Ford, et al.
Cancer Research|November 1, 1984
Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cellsR Ganapathi, D Grabowski, W Rouse, et al.
Journal of Fish Diseases|October 16, 2004
Systemic and mucosal antibody response in tilapia, Oreochromis niloticus (L.), following immunization with Flavobacterium columnareL D Grabowski, S E LaPatra, K D Cain
Biochemical Pharmacology|December 24, 1996
Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylationK Kawamura, D Grabowski, K Krivacic, et al.
Biochemical and Biophysical Research Communications|September 16, 1985
Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cellsR Ganapathi, D Grabowski, H Schmidt, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Health Physics|August 1, 1972
Long-term study of the urinary Strontium-90 and calcium in childrenW Czosnowska, Z Pietrzak-Flis, D Grabowski
Diabetic Medicine : a Journal of the British Diabetic Association|July 4, 2020
The psychosocial experience and needs of children newly diagnosed with type 1 diabetes from their own perspective: a systematic and narrative reviewP DeCosta, D Grabowski, T C Skinner
European Journal of Cancer & Clinical Oncology|June 1, 1984
Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cellsR Ganapathi, D Grabowski, R Turinic, et al.
Biochemical Pharmacology|October 1, 1990
Modulation of doxorubicin-induced chromosomal damage by calmodulin inhibitors and its relationship to cytotoxicity in progressively doxorubicin-resistant tumor cellsR Ganapathi, D Grabowski, G Hoeltge, et al.
Cancer Research|July 15, 1993
Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin)R Ganapathi, A Hercbergs, D Grabowski, et al.
British Journal of Cancer|June 1, 1993
Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotypeN Kamath, D Grabowski, J Ford, et al.
Cancer Research|November 1, 1984
Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cellsR Ganapathi, D Grabowski, W Rouse, et al.
Journal of Fish Diseases|October 16, 2004
Systemic and mucosal antibody response in tilapia, Oreochromis niloticus (L.), following immunization with Flavobacterium columnareL D Grabowski, S E LaPatra, K D Cain
Biochemical Pharmacology|December 24, 1996
Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylationK Kawamura, D Grabowski, K Krivacic, et al.
Biochemical and Biophysical Research Communications|September 16, 1985
Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cellsR Ganapathi, D Grabowski, H Schmidt, et al.
Pageof 5